悦达国际控股(00629) - 2025 - 年度业绩

Supplemental Announcement Regarding the 2024 Annual Report This section provides supplementary information to the 2024 Annual Report, covering share options, continuing connected transactions, and other corporate details Share Options This section details the company's share option scheme, including authorized total, unexercised status, participant entitlement limits, exercise period, and minimum vesting period Total Authorized Share Options This subsection presents the total number of share options authorized under the scheme and their proportion to issued shares Authorized Share Options Overview | Metric | Value | | :--- | :--- | | Total share options authorized for grant under the scheme | 116,862,651 options | | Total company shares available for issue under the scheme | 116,862,651 shares | | Percentage of total issued company shares (excluding treasury shares) | 10% | Unexercised Share Options Status This subsection clarifies the current status of unexercised share options under the company's scheme - As of December 31, 2024, there were no unexercised share options under the scheme[5] Maximum Entitlement per Participant This subsection addresses the limits on entitlements for individual participants within the share option scheme - The share option scheme rules do not specify a maximum entitlement per participant, but the company will continuously monitor compliance with Chapter 17 of the Listing Rules[6] Share Option Exercise Period This subsection defines the permissible timeframe for exercising share options granted under the scheme - Share options are exercisable within a period determined by the directors and notified to the grantee, not exceeding ten years from the offer date of the share option[7] Minimum Vesting Period This subsection outlines the minimum holding period required before share options become exercisable - Unless otherwise determined by the directors and stated in the offer to the grantee, there is no minimum vesting period required before share options become exercisable[8] Continuing Connected Transactions and Connected Transactions This section details the company's compliance with continuing connected transactions, including auditor's unqualified opinion and confirmation of adherence to Listing Rules for disclosed transactions Auditor's Opinion This subsection presents the auditor's findings and conclusions regarding the company's continuing connected transactions - The company's auditor has issued an unqualified opinion letter in accordance with Listing Rule 14A.56, containing findings and conclusions on the continuing connected transactions described on page 65 of the 2024 Annual Report[9] Transaction Disclosure and Compliance Confirmation This subsection confirms the company's compliance with Listing Rules for disclosed transactions and clarifies other related party transactions - The company confirms compliance with Chapter 14A of the Listing Rules for transactions under the termination agreement and the 2023 factoring agreement (the 'Disclosed Transactions')[9][10] - Other related party transactions disclosed in Notes 14 and 31 to the consolidated financial statements in the 2024 Annual Report do not constitute connected transactions or continuing connected transactions requiring announcement, circular, shareholder approval, and/or reporting under Chapter 14A of the Listing Rules[9] Impact on Annual Report This subsection clarifies that the supplementary information does not alter the original content of the 2024 Annual Report - The supplementary information does not affect other data contained in the 2024 Annual Report, and the content of the 2024 Annual Report remains unchanged[10] Other Information This section includes the board's statement, a list of board members, and the principle for resolving inconsistencies between language versions Board Members This subsection lists the current composition of the company's Board of Directors as of the announcement date - As of the announcement date, the Board of Directors includes Executive Directors Mr Ji Hulin, Mr Xue Zhicheng, Mr Pan Mingfeng, and Dr Teng Songsong; Non-executive Directors Mr Li Biao and Mr Hu Huaimin; and Independent Non-executive Directors Dr Liu Yongping, Mr Zhang Tingji, and Ms Zhang Yan[12] Language Version Statement This subsection specifies the authoritative language version in case of discrepancies in the announcement - In case of any inconsistency between the English and Chinese versions of this announcement, the English version shall prevail[13]